Lorraine B Ware Selected Research

Prostaglandins D

1/2021	Risk of primary graft dysfunction following lung transplantation in selected adults with connective tissue disease-associated interstitial lung disease.
12/2019	Adipose tissue quantification and primary graft dysfunction after lung transplantation: The Lung Transplant Body Composition study.
1/2018	Cell-free hemoglobin promotes primary graft dysfunction through oxidative lung endothelial injury.
1/2018	Quantitative Evidence for Revising the Definition of Primary Graft Dysfunction after Lung Transplant.
9/2017	Cell-Free Hemoglobin-mediated Increases in Vascular Permeability. A Novel Mechanism of Primary Graft Dysfunction and a New Therapeutic Target.
1/2017	Primary graft dysfunction: pathophysiology to guide new preventive therapies.
4/2016	The relationship between plasma lipid peroxidation products and primary graft dysfunction after lung transplantation is modified by donor smoking and reperfusion hyperoxia.
2/2015	Neutrophil extracellular traps are pathogenic in primary graft dysfunction after lung transplantation.
3/2014	Genetic variation in the prostaglandin E2 pathway is associated with primary graft dysfunction.
8/2013	Latent class analysis identifies distinct phenotypes of primary graft dysfunction after lung transplantation.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lorraine B Ware Research Topics

Disease

73	Acute Lung Injury 01/2022 - 03/2002
71	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 05/2022 - 11/2002
42	Sepsis (Septicemia) 01/2022 - 09/2003
37	Pulmonary Edema 03/2022 - 03/2002
35	Inflammation (Inflammations) 05/2022 - 03/2002
33	Critical Illness (Critically Ill) 01/2022 - 06/2002
27	Primary Graft Dysfunction 01/2021 - 01/2007
26	Lung Injury 01/2022 - 01/2003
19	Edema (Dropsy) 01/2021 - 11/2002
16	Acute Kidney Injury (Acute Renal Failure) 01/2021 - 12/2007
11	Wounds and Injuries (Trauma) 01/2020 - 10/2007
10	Pneumonia (Pneumonitis) 03/2022 - 05/2002
10	Shock 01/2022 - 07/2011
9	Chronic Obstructive Pulmonary Disease (COPD) 03/2022 - 09/2007
8	Respiratory Insufficiency (Respiratory Failure) 01/2022 - 06/2002
8	Lung Diseases (Lung Disease) 01/2022 - 05/2002
7	Kidney Diseases (Kidney Disease) 01/2021 - 01/2011
7	Hypoxia (Hypoxemia) 12/2020 - 11/2002
6	Hyperoxia 01/2022 - 11/2006
5	Obesity 07/2022 - 09/2010
5	Idiopathic Pulmonary Fibrosis 01/2021 - 03/2010
5	Delirium 01/2020 - 12/2012
4	COVID-19 10/2022 - 01/2021
4	Neoplasms (Cancer) 01/2022 - 03/2010
4	Asthma (Bronchial Asthma) 01/2022 - 09/2007
4	Necrosis 01/2021 - 12/2004
4	Infections 01/2018 - 04/2007
4	Pulmonary Arterial Hypertension 10/2017 - 01/2004
3	Cystic Fibrosis (Mucoviscidosis) 01/2022 - 09/2007
3	Fibrosis (Cirrhosis) 01/2021 - 04/2012
3	Pulmonary Hypertension 10/2017 - 01/2004
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2021 - 12/2007

Drug/Important Bio-Agent (IBA)

68	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2003
23	Proteins (Proteins, Gene)FDA Link 03/2022 - 11/2002
21	Prostaglandins DIBA 01/2021 - 01/2007
17	Protein CIBA 01/2022 - 09/2003
16	Hemoglobins (Hemoglobin)IBA 01/2021 - 03/2013
15	Biological ProductsIBA 03/2022 - 10/2007
11	Oxygen (Dioxygen)IBA 01/2022 - 01/2003
11	CytokinesIBA 01/2020 - 08/2007
10	CreatinineIBA 12/2020 - 12/2007
10	Thromboplastin (Tissue Factor)IBA 02/2016 - 08/2006
9	von Willebrand FactorIBA 06/2019 - 10/2004
8	Plasminogen Activator Inhibitor 1IBA 01/2019 - 07/2003
7	SmokeIBA 03/2022 - 01/2011
7	Interleukin-6 (Interleukin 6)IBA 01/2021 - 02/2004
7	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 10/2007
7	Interleukin-8 (Interleukin 8)IBA 01/2021 - 12/2007
7	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2020 - 03/2013
7	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 06/2019 - 01/2003
7	AntigensIBA 06/2015 - 07/2003
7	FibrinIBA 10/2011 - 09/2005
6	ThrombomodulinIBA 05/2016 - 09/2003
6	Blood Proteins (Serum Proteins)IBA 09/2012 - 05/2004
5	Lipocalin-2IBA 10/2019 - 08/2009
5	Plasminogen Activators (Plasminogen Activator)IBA 01/2016 - 07/2003
5	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 02/2010 - 07/2003
4	Secretory Immunoglobulin A (SIgA)IBA 01/2022 - 08/2011
4	Surface-Active Agents (Surfactants)IBA 01/2022 - 01/2003
4	Receptor for Advanced Glycation End ProductsIBA 05/2021 - 05/2006
4	Messenger RNA (mRNA)IBA 01/2021 - 11/2002
4	Angiopoietin-2IBA 01/2021 - 09/2010
4	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2021 - 03/2005
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 06/2011
4	Oxidants (Oxidizing Agents)IBA 01/2020 - 11/2006
4	HaptoglobinsIBA 01/2020 - 11/2013
4	InterleukinsIBA 06/2019 - 02/2010
3	AlbuminsIBA 09/2021 - 03/2011
3	Interleukin-12 (IL 12)IBA 01/2021 - 11/2012
3	Nicotine FDA Link 01/2021 - 11/2004
3	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 01/2018
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020 - 02/2007
3	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 06/2019 - 01/2011
3	drotrecogin alfa activated (Xigris)FDA Link 01/2018 - 01/2008
3	Bleomycin (Blenoxane)FDA LinkGeneric 02/2016 - 04/2012
3	Interleukin-18 (Interleukin 18)IBA 03/2015 - 08/2010
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 12/2004
2	ChemokinesIBA 01/2022 - 11/2018
2	Interleukin-4 (Interleukin 4)IBA 01/2022 - 01/2021
2	Interleukin-33IBA 01/2022 - 11/2018
2	Immunoglobulin A (IgA)IBA 01/2022 - 12/2015
2	Polymeric Immunoglobulin Receptors (Polymeric Immunoglobulin Receptor)IBA 01/2022 - 08/2011
2	DiureticsIBA 07/2021 - 01/2005
2	Syndecan-1 (Syndecan 1)IBA 01/2021 - 10/2017
2	Cadherins (E-Cadherin)IBA 01/2021 - 01/2019
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 11/2002
2	Interleukin-10 (Interleukin 10)IBA 01/2021 - 12/2007
2	C-Reactive ProteinIBA 01/2021 - 12/2012

Therapy/Procedure

28	Lung Transplantation 01/2021 - 01/2007
27	Therapeutics 01/2022 - 03/2005
14	Mechanical Ventilators (Ventilator) 07/2021 - 10/2002
13	Artificial Respiration (Mechanical Ventilation) 01/2022 - 07/2003
11	Critical Care (Surgical Intensive Care) 10/2022 - 12/2004
6	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 01/2022 - 02/2010
6	Transplantation 10/2017 - 11/2002
5	Cardiopulmonary Bypass (Heart-Lung Bypass) 01/2018 - 11/2011
4	Precision Medicine 01/2022 - 01/2020
3	Intraperitoneal Injections 01/2022 - 10/2019
3	Length of Stay 01/2018 - 04/2009